| NDC Code | 70461-123-03 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (70461-123-03) / .5 mL in 1 SYRINGE, GLASS (70461-123-04) |
|---|
| Product NDC | 70461-123 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Fluad Quadrivalent |
|---|
| Non-Proprietary Name | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/6/2021 Ivr-227 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (formaldehyde Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20230701 |
|---|
| End Marketing Date | 20240731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125510 |
|---|
| Manufacturer | Seqirus, Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|